Benzinga's Top Upgrades, Downgrades For March 13, 2017

Top Upgrades

• Raymond James upgraded Finisar Corporation (NASDAQ: FNSR) from Outperform to Strong Buy. Finisar shares rose 1.78 percent to $27.46 in pre-market trading.
• B. Riley upgraded Kirkland's, Inc. (NASDAQ: KIRK) from Neutral to Buy. Kirkland's shares gained 1.15 percent to close at $11.47 on Friday.
• Morgan Stanley upgraded Rockwell Collins, Inc. (NYSE: COL) from Equal-Weight to Overweight. Rockwell Collins shares rose 1.53 percent to $98.70 in pre-market trading.
• Analysts at RBC Capital upgraded Gartner Inc (NYSE: IT) from Outperform to Top Pick. Gartner shares gained 3.78 percent to $109.95 in pre-market trading.
• Baird upgraded Kimco Realty Corp (NYSE: KIM) from Neutral to Outperform. Kimco Realty shares gained 0.23 percent to close at $21.64 on Friday.
• Analysts at Stifel Nicolaus upgraded Targa Resources Corp (NYSE: TRGP) from Hold to Buy. Targa Resources shares rose 0.36 percent to close at $55.72 on Friday.
• Analysts at Janney Capital upgraded Acorda Therapeutics Inc (NASDAQ: ACOR) from Neutral to Buy. Acorda Therapeutics shares rose 1.78 percent to $28.65 in pre-market trading.
• Analysts at Credit Suisse upgraded Scorpio Bulkers Inc (NYSE: SALT) from Neutral to Outperform. Scorpio Bulkers shares rose 5.23 percent to $8.05 in pre-market trading.
• Analysts at Goldman Sachs upgraded Blueprint Medicines Corp (NASDAQ: BPMC) from Neutral to Buy. Blueprint Medicines shares climbed 8.53 percent to close at $39.32 on Friday.
• JP Morgan upgraded Geopark Ltd (NYSE: GPRK) from Neutral to Overweight. Geopark shares fell 0.16 percent to close at $6.10 on Friday.

Top Downgrades

• Deutsche Bank downgraded American International Group Inc (NYSE: AIG) from Hold to Sell. AIG shares slipped 1.38 percent to $62.21 in pre-market trading.
• JMP Securities downgraded Patriot National Inc (NYSE: PN) from Market Outperform to Market Perform. Patriot National shares gained 5.23 percent to close at $3.42 on Friday.
• Analysts at Morgan Stanley downgraded Boeing Co (NYSE: BA) from Overweight to Equal-Weight. Boeing shares fell 0.85 percent to $177.18 in pre-market trading.
• Analysts at Telsey Advisory Group downgraded GameStop Corp. (NYSE: GME) from Outperform to Market Perform. GameStop shares declined 0.79 percent to $24.98 in pre-market trading.
• RBC Capital downgraded Aramark (NYSE: ARMK) from Top Pick to Outperform. Aramark shares rose 0.58 percent to close at $36.52 on Friday.
• Analysts at Goldman Sachs downgraded Johnson Controls International plc (NYSE: JCI) from Buy to Neutral. Johnson Controls shares rose 1 percent to close at $41.23 on Friday.
• Citigroup downgraded Unum Group (NYSE: UNM) from Buy to Neutral. Unum shares fell 0.02 percent to close at $48.81 on Friday.
• Williams Financial downgraded Silver Spring Networks Inc (NYSE: SSNI) from Buy to Hold. Silver Spring Networks shares fell 5.57 percent to $10.51 in pre-market trading.

Top Initiations

• Analysts at Wells Fargo initiated coverage on John Bean Technologies Corp (NYSE: JBT) with a Outperform rating. John Bean Technologies shares closed at $88.05 on Friday.
• Analysts at B. Riley initiated coverage on Six Flags Entertainment Corp (NYSE: SIX) with a Buy rating. The price target for Six Flags is set to $67. Six Flags shares closed at $59.70 on Friday.
• Analysts at UBS initiated coverage on E*TRADE Financial Corp (NASDAQ: ETFC) with a Buy rating. The price target for E*TRADE is set to $43. E*TRADE shares closed at $35.15 on Friday.
• Analysts at Canaccord Genuity initiated coverage on Health Insurance Innovations Inc (NASDAQ: HIIQ) with a Buy rating. Health Insurance Innovations shares closed at $15.75 on Friday.
• Analysts at Jefferies initiated coverage of Ferrari N.V. (NYSE: RACE) with a Buy rating. Ferrari shares closed at $65.73 on Friday.
• Analysts at B. Riley initiated coverage on CoStar Group Inc (NASDAQ: CSGP) with a Buy rating. The price target for CoStar Group is set to $231. CoStar Group shares closed at $205.18 on Friday.
• Analysts at Jefferies assumed coverage of Xenon Pharmaceuticals Inc (NASDAQ: XENE) with a Buy rating. The price target for Xenon Pharmaceuticals is set to $13. Xenon Pharmaceuticals shares closed at $8.35 on Friday.